We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$43.9B
AUM Growth
+$1.29B
Cap. Flow
+$573M
Cap. Flow %
1.31%
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Healthcare 13.05%
3 Financials 12.83%
4 Industrials 10.11%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTX icon
2876
Context Therapeutics
CNTX
$44.5M
$27.8K ﹤0.01%
+13,844
New +$23.9K
ZURAW
2877
DELISTED
Zura Bio Limited Warrants
ZURAW
$26.4K ﹤0.01%
66,017
+44,517
+207% +$22.6K
CUTR
2878
DELISTED
Cutera, Inc.
CUTR
$25.8K ﹤0.01%
17,062
-6,532
-28% -$13.1K
LUXH
2879
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$25.7K ﹤0.01%
+1,570
New +$69.8K
CMRX
2880
DELISTED
Chimerix, Inc.
CMRX
$25.6K ﹤0.01%
29,278
-19,833
-40% -$18.8K
OTLY
2881
Oatly Group
OTLY
$438M
$25.2K ﹤0.01%
+1,341
New +$28.5K
NEON icon
2882
Neonode
NEON
$16.2M
$25.2K ﹤0.01%
12,181
-8,974
-42% -$19.2K
CAUD
2883
DELISTED
Collective Audience, Inc.. Common Stock
CAUD
$24.6K ﹤0.01%
+45,434
New +$22.4K
IHRT icon
2884
iHeartMedia
IHRT
$583M
$23.3K ﹤0.01%
21,387
-323,749
-94% -$504K
PED icon
2885
PEDEVCO
PED
$141M
$22.8K ﹤0.01%
1,261
-77
-6% -$1.4K
CMMB
2886
Chemomab Therapeutics
CMMB
$14.1M
$22.3K ﹤0.01%
6,099
-3,900
-39% -$13.5K
FBRX icon
2887
Forte Biosciences
FBRX
$1.57B
$21.9K ﹤0.01%
1,632
-3
-0.2% -$48
GB.WS
2888
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$21.4K ﹤0.01%
267,230
+37,130
+16% +$2.45K
EVLVW
2889
DELISTED
Evolv Technologies Warrant
EVLVW
$20.9K ﹤0.01%
+77,700
New +$28K
SNTI icon
2890
Senti Biosciences Holdings
SNTI
$11M
$19.3K ﹤0.01%
6,975
-2,387
-25% -$7.74K
ACHL
2891
DELISTED
Achilles Therapeutics
ACHL
$17.5K ﹤0.01%
21,478
+9,679
+82% +$8.51K
VEEE icon
2892
Twin Vee PowerCats
VEEE
$4.85M
$16.5K ﹤0.01%
82
-3
-4% -$826
FRGT icon
2893
Freight Technologies
FRGT
$1.57M
$16.4K ﹤0.01%
+19
New +$35K
ICCM icon
2894
IceCure Medical
ICCM
$10.6M
$15.7K ﹤0.01%
+709
New +$22.6K
XPON icon
2895
Expion360
XPON
$3.31M
$15.4K ﹤0.01%
+13
New +$28.5K
ICAD
2896
DELISTED
iCAD Inc
ICAD
$15K ﹤0.01%
11,542
-7,012
-38% -$10.8K
SPRB
2897
Spruce Biosciences
SPRB
$129M
$14.8K ﹤0.01%
381
-1,259
-77% -$67.5K
HCWB icon
2898
HCW Biologics
HCWB
$5.45M
$14.5K ﹤0.01%
94
HCTI icon
2899
Healthcare Triangle
HCTI
$2.53M
$14.1K ﹤0.01%
+2
New +$31K
ANY icon
2900
Sphere 3D
ANY
$16M
$13.9K ﹤0.01%
+1,286
New +$14.5K

Similar funds

Two Sigma Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Two Sigma Investments held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Two Sigma Investments's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
  • Two Sigma Investments added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
  • Two Sigma Investments's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
  • Two Sigma Investments fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
  • Two Sigma Investments's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
  • Two Sigma Investments opened 479 new positions and closed 480 in Q2 2024.
  • Two Sigma Investments's portfolio value rose 3% quarter-over-quarter to $43.9B.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.